Our findings indicated a significant upregulation of fibrotic markers, specifically fibronectin and α-SMA, in the lung tissues of IPF patients, accompanied by a marked 2.48-fold increase in SIK2 protein levels (p < 0.05) (Figure 1A). The gene discussed is SIK2; the disease is idiopathic pulmonary fibrosis.